society of nuclear medicine

(Society of Nuclear Medicine) Positron emission tomography and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method for imaging a form of Non-Hodgkin's disease called mantle cell lymphoma, a relatively rare and devastating blood cancer.

(Society of Nuclear Medicine) For patients with non-small cell lung cancer the accurate determination of the lymph node status before therapy is critical to develop an individualized treatment plan.

Research from the October issue of the Journal of Nuclear Medicine highlights a new way for this information to be collected -- a virtual fly-through three-dimensional 18F-FDG PET/computed tomography bronchoscopy that has high diagnostic accuracy for the detection of regional lymph node metastases.

(Society of Nuclear Medicine) According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer diagnosis.

While many neuroendocrine cancers are incurable, they grow relatively slowly, and life expectancy is relatively long, making quality of life an important factor in treatment.

(Society of Nuclear Medicine) A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of the Journal of Nuclear Medicine.

(Society of Nuclear Medicine) Research presented at SNM's 58th Annual Meeting highlights molecular imaging's diagnostic potential for patients with fever of unknown origin.

(The Endocrine Society) The growing concern surrounding the release of radiation from an earthquake and tsunami-stricken nuclear complex in Japan has raised fears of radiation exposure to populations in North America from the potential plume of radioactivity crossing the Pacific Ocean.

To help Americans understand their radiation-related health risks, the American Association of Clinical Endocrinologists (AACE), the American Thyroid Association (ATA), The Endocrine Society and the Society of Nuclear Medicine (SNM) issued a joint statement.

(Society of Nuclear Medicine) A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA).

RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to undergo surgery or other therapies to treat lung cancer.

(Society of Nuclear Medicine) A series of studies published in the September Journal of Nuclear Medicine (JNM) show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphoma.

(Society of Nuclear Medicine) A study published in the August Journal of Nuclear Medicine (JNM) finds that molecular imaging -- a noninvasive imaging procedure -- can identify high-risk patients with potentially life-threatening cardiovascular conditions and help physicians determine which patients are best suited for implantable cardioverter defibrillator (ICD) therapy.

(Society of Nuclear Medicine) Bengt Roland Långström, Ph.D., a professor in the department of biochemistry and organic chemistry at Uppsala University in Sweden, has been named as this year's recipient of the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession.